Response to neoadjuvant chemotherapy according to molecular subtypes in muscle-invasive bladder carcinoma.

被引:0
作者
Pinto, Alvaro
Trilla-Fuertes, Lucia
Pedregosa-Barbas, Jorge
Garcia-Fernandez, Eugenia
Wisultschew-Puigdellivol, Alma L.
Zambrana, Francisco
Martinez, Imanol
Gajate, Pablo
Dittmann, Antje
Lopez Vacas, Rocio
Kunz, Laura
Rubio, Gustavo
Nieto-Torrero, Sandra
Lalanda-Delgado, Pedro
Pertejo, Ana
Saiz, Ana
Pilar Gonzalez-Peramato, Maria
Angel Fresno-Vara, Juan
Gamez-Pozo, Angelo
机构
[1] Univ Hosp La Paz IdiPAZ, Dept Med Oncol, Madrid, Spain
[2] Univ Hosp La Paz, Dept Med Oncol, IdiPAZ, Mol Oncol Lab,INGEMM, Madrid, Spain
[3] Univ Hosp La Paz IdiPAZ, Dept Pathol, Madrid, Spain
[4] Univ Hosp La Paz IdiPAZ, INGEMM, Mol Oncol Lab, Madrid, Spain
[5] Infanta Sofia Univ Hosp, Dept Med Oncol, Madrid, Spain
[6] Jimenez Diaz Fdn Univ Hosp, Dept Med Oncol, Madrid, Spain
[7] Univ Hosp Ramon & Cajal, Dept Med Oncol, Madrid, Spain
[8] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland
[9] Univ Hosp La Paz IdiPAZ, IdiPAZ Biobank, Madrid, Spain
[10] Univ Hosp La Paz IdiPAZ, Mol Oncol Lab, Madrid, Spain
[11] Univ Hosp Ramon & Cajal, Pathol Deparment, Madrid, Spain
[12] Univ Hosp La Paz IdiPAZ, Biomed Res Networking Ctr Oncol CIBERONC, ISCIII, Mol Oncol Lab, Madrid, Spain
基金
欧盟地平线“2020”;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16605
引用
收藏
页数:1
相关论文
empty
未找到相关数据